CYDNEY NEWTON- SMITH: Open Payments
NPI 1033653803 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 30 payments from 10 companies in 2025. Trend: 2023 $384 · 2024 $156 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $172 |
| ABBVIE INC. | 14 | $166 |
| Abbott Laboratories | 1 | $133 |
| Novo Nordisk Inc | 1 | $105 |
| Braeburn Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| ViiV Healthcare Company | 1 | $20 |
| Organon LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: MOUNJARO, FREESTYLE LIBRE 3, Ozempic, VRAYLAR, MAVYRET, BRIXADI, ABILIFY ASIMTUFII, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
